rs112723370 - HCP5
Magnitude 4.5 · 1 study on file
Reported associations
-
Genome-wide meta-analysis reveals novel susceptibility loci for thyrotoxic periodic paralysis. - European journal of endocrinology (2020) · Hoi-Yee Li G, Cheung CL, Zhao SX, Song HD, Wai-Chee Kung A · PubMed 33105104
Thyrotoxic periodic paralysis (TPP) is a rare and potentially fatal complication of hyperthyroidism. By meta-analysis of genome-wide association studies, we aim to discover novel susceptibility loci and understand the pathogenesis of TPP. This meta-analysis comprised 319 TPP cases and 3516 healthy controls from three independent cohorts (two from Hong Kong; one from Shanghai). Genetic variants in each cohort were separately genotyped, imputed and analyzed for association with TPP. Fixed-effect meta-analysis was performed to combine the data. Using the three independent genome-wide significant variants, a weighted genetic risk score (GRS) was developed. Of 7 077 246 variants tested for association with TPP, 260 variants reached genome-wide significance and were represented by independent va
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Screening
-
Thyroid function and periodic paralysis symptoms Moderate
rs112723370 T allele is strongly associated with thyrotoxic periodic paralysis (GWAS p=5e-10)
Annual thyroid testing and track muscle weakness episodes